Glucose-regulated protein 78 in the aqueous humor in diabetic macular edema patients

Area of Science:

• Ophthalmology
• Endocrinology
• Molecular Biology

Background:

• Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
• Understanding the molecular mechanisms underlying DME is crucial for developing effective treatments.
• Glucose-regulated protein 78 (GRP78) is a stress-inducible protein implicated in various cellular processes.

Purpose of the Study:

• To investigate the presence and levels of GRP78 in the aqueous humor of patients with DME.
• To analyze the correlation between GRP78 levels and vascular endothelial growth factor (VEGF) in DME.
• To examine factors associated with GRP78 levels, including diabetes duration and response to anti-VEGF therapy.

Main Methods:

• Aqueous humor samples were collected from DME patients and control subjects.
• GRP78 and VEGF levels were quantified using appropriate assays.
• Statistical analyses, including stepwise backward regression, were performed to identify associations.

Main Results:

• GRP78 was detected in aqueous humor and found to be significantly elevated in DME patients compared to controls.
• GRP78 levels showed a significant positive correlation with VEGF levels and duration of diabetes.
• No significant association was found between GRP78 levels and the reduction in central subfield thickness (CST) after anti-VEGF treatment.

Conclusions:

• GRP78 is upregulated in the aqueous humor of patients with DME.
• Elevated GRP78 levels in DME are associated with increased VEGF and longer diabetes duration.
• GRP78 levels do not appear to be a predictive biomarker for anti-VEGF treatment response in DME.